Exploring Oesophageal Cancer in Ethiopia: Elevated Incidence in Females and Younger Cases.

Autor: Mulisa G; Department of Microbiology, Immunology & Parasitology, Addis Ababa University, Addis Ababa, Addis Ababa, Ethiopia.; Department of Biomedical Science, Adama Hospital Medical College, Adama, Ethiopia., Abebe T; Department of Microbiology, Immunology & Parasitology, Addis Ababa University, Addis Ababa, Addis Ababa, Ethiopia., Gutema B; Department of Medical Laboratory Science, Arsi University, Asella, Ethiopia., Mahmuda J; Shahjalal University of Science and Technology, Sylhet, Bangladesh., Khan MAA; Shahjalal University of Science and Technology, Sylhet, Bangladesh.; Toxicology Society of Bangladesh, Bangladesh., Gheit T; International Agency for Research on Cancer, Lyon, France., Herceg Z; International Agency for Research on Cancer, Lyon, France., Talukdar FR; International Agency for Research on Cancer, Lyon, France.; Cancer Research UK Cambridge Institute, Li ka Shing Centre, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Li ka Shing Centre, Cambridge, UK.

Publikováno v: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Dec; Vol. 7 (12), pp. e70048.

Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth.

Autor: Ghantous A; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, (IARC), 25 avenue Tony Garnier, CS 90627, Lyon, Cedex 07 69366, France. GhantousA@iarc.who.int., Nusslé SG; Genknowme SA, Alanine Building, Corniche Road 5, 1066, Epalinges, Switzerland., Nassar FJ; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, (IARC), 25 avenue Tony Garnier, CS 90627, Lyon, Cedex 07 69366, France., Spitz N; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, (IARC), 25 avenue Tony Garnier, CS 90627, Lyon, Cedex 07 69366, France., Novoloaca A; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, (IARC), 25 avenue Tony Garnier, CS 90627, Lyon, Cedex 07 69366, France., Krali O; Department of Medical Sciences, Molecular Precision Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Nickels E; Center for Genetic Epidemiology, University of Southern California, Los Angeles, USA.; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, USA., Cahais V; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, (IARC), 25 avenue Tony Garnier, CS 90627, Lyon, Cedex 07 69366, France., Cuenin C; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, (IARC), 25 avenue Tony Garnier, CS 90627, Lyon, Cedex 07 69366, France., Roy R; Computational Biology and Informatics Core, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, USA., Li S; Center for Genetic Epidemiology, University of Southern California, Los Angeles, USA., Caron M; Department of Pediatrics, University of Montreal & Research Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, Quebec, Canada., Lam D; School of Molecular Sciences, The University of Western Australia, Crawley, Western Australia, 6009, Australia.; Harry Perkins Institute of Medical Research, Nedlands, Western Australia, 6009, Australia., Fransquet PD; Centre for Social and Early Emotional Development (SEED), School of Psychology, Deakin University, Burwood, Victoria, Australia., Casement J; Bioinformatics Support Unit, Newcastle University, Newcastle upon Tyne, UK., Strathdee G; Newcastle University Centre for Cancer, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK., Pearce MS; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK., Hansen HM; Neuro and Molecular Epidemiology Laboratory, University of California San Francisco, San Francisco, USA., Lee HH; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, 10408, Korea., Lee YS; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, 10408, Korea., de Smith AJ; Center for Genetic Epidemiology, University of Southern California, Los Angeles, USA., Sinnett D; Department of Pediatrics, University of Montreal & Research Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, Quebec, Canada., Håberg SE; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., McKay JA; Department of Applied Sciences, Northumbria University, Newcastle upon Tyne, UK., Nordlund J; Department of Medical Sciences, Molecular Precision Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Magnus P; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Dwyer T; Clinical Sciences Theme, Heart Group, Murdoch Children's Research Institute, Melbourne, Australia.; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, UK.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia., Saffery R; Murdoch Children's Research Institute and Department of Paediatrics, University of Melbourne, Melbourne, Australia., Wiemels JL; Center for Genetic Epidemiology, University of Southern California, Los Angeles, USA., Munthe-Kaas MC; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.; Department of Pediatric Oncology and Hematology, Oslo University Hospital, Oslo, Norway., Herceg Z; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, (IARC), 25 avenue Tony Garnier, CS 90627, Lyon, Cedex 07 69366, France. HercegZ@iarc.who.int.

Publikováno v: Molecular cancer [Mol Cancer] 2024 Oct 23; Vol. 23 (1), pp. 238. Date of Electronic Publication: 2024 Oct 23.

The interplay of dietary mycotoxins and oncogenic viruses toward human carcinogenesis: a scoping review.

Autor: Mouchtaris Michailidis T; Faculty of Pharmaceutical Sciences, Centre of Excellence in Mycotoxicology and Public Health, Ghent University, Ghent, Belgium.; CRIG, Cancer Research Institute Ghent, Ghent, Belgium.; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France., De Saeger S; Faculty of Pharmaceutical Sciences, Centre of Excellence in Mycotoxicology and Public Health, Ghent University, Ghent, Belgium.; CRIG, Cancer Research Institute Ghent, Ghent, Belgium.; Department of Biotechnology and Food Technology, Faculty of Science, University of Johannesburg, Johannesburg, South Africa., Khoueiry R; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France., Odongo GA; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Institute of Cancer Research and Genomics Sciences, University of Birmingham, Birmingham, UK., Bader Y; Faculty of Pharmaceutical Sciences, Centre of Excellence in Mycotoxicology and Public Health, Ghent University, Ghent, Belgium.; CRIG, Cancer Research Institute Ghent, Ghent, Belgium., Dhaenens M; Laboratory of Pharmaceutical Biotechnology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium., Herceg Z; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France., De Boevre M; Faculty of Pharmaceutical Sciences, Centre of Excellence in Mycotoxicology and Public Health, Ghent University, Ghent, Belgium.; CRIG, Cancer Research Institute Ghent, Ghent, Belgium.

Publikováno v: Critical reviews in food science and nutrition [Crit Rev Food Sci Nutr] 2024 Oct 18, pp. 1-19. Date of Electronic Publication: 2024 Oct 18.

Epigenetics as a mechanism linking developmental exposures to long-term toxicity

Autor: Barouki, R., Melén, E., Herceg, Z., Beckers, J., Chen, J., Karagas, M., Puga, A., Xia, Y., Chadwick, L., Yan, W., Audouze, K., Slama, R., Heindel, J., Grandjean, P., Kawamoto, T., Nohara, K.

Publikováno v: In Environment International May 2018 114:77-86

Advisory Group recommendations on priorities for the IARC Monographs.

Autor: Berrington de González A; International Agency for Research on Cancer, Lyon, France., Masten SA; International Agency for Research on Cancer, Lyon, France., Bhatti P; International Agency for Research on Cancer, Lyon, France., Fortner RT; International Agency for Research on Cancer, Lyon, France., Peters S; International Agency for Research on Cancer, Lyon, France., Santonen T; International Agency for Research on Cancer, Lyon, France., Yakubovskaya MG; International Agency for Research on Cancer, Lyon, France., Barouki R; International Agency for Research on Cancer, Lyon, France., Barros SBM; International Agency for Research on Cancer, Lyon, France., Barupal D; International Agency for Research on Cancer, Lyon, France., Beane Freeman LE; International Agency for Research on Cancer, Lyon, France., Calaf GM; International Agency for Research on Cancer, Lyon, France., Dillner J; International Agency for Research on Cancer, Lyon, France., El Rhazi K; International Agency for Research on Cancer, Lyon, France., Fritschi L; International Agency for Research on Cancer, Lyon, France., Fukushima S; International Agency for Research on Cancer, Lyon, France., Godderis L; International Agency for Research on Cancer, Lyon, France., Kogevinas M; International Agency for Research on Cancer, Lyon, France., Lachenmeier DW; International Agency for Research on Cancer, Lyon, France., Mandrioli D; International Agency for Research on Cancer, Lyon, France., Muchengeti MM; International Agency for Research on Cancer, Lyon, France., Niemeier RT; International Agency for Research on Cancer, Lyon, France., Pappas JJ; International Agency for Research on Cancer, Lyon, France., Pi J; International Agency for Research on Cancer, Lyon, France., Purdue MP; International Agency for Research on Cancer, Lyon, France., Riboli E; International Agency for Research on Cancer, Lyon, France., Rodríguez T; International Agency for Research on Cancer, Lyon, France., Schlünssen V; International Agency for Research on Cancer, Lyon, France., Benbrahim-Tallaa L; International Agency for Research on Cancer, Lyon, France., de Conti A; International Agency for Research on Cancer, Lyon, France., Facchin C; International Agency for Research on Cancer, Lyon, France., Pasqual E; International Agency for Research on Cancer, Lyon, France., Wedekind R; International Agency for Research on Cancer, Lyon, France., Ahmadi A; International Agency for Research on Cancer, Lyon, France., Chittiboyina S; International Agency for Research on Cancer, Lyon, France., Herceg Z; International Agency for Research on Cancer, Lyon, France., Kulasingam S; International Agency for Research on Cancer, Lyon, France., Lauby-Secretan B; International Agency for Research on Cancer, Lyon, France., MacLehose R; International Agency for Research on Cancer, Lyon, France., Sanaa M; International Agency for Research on Cancer, Lyon, France., Schüz J; International Agency for Research on Cancer, Lyon, France., Suonio E; International Agency for Research on Cancer, Lyon, France., Zavadil J; International Agency for Research on Cancer, Lyon, France., Mattock H; International Agency for Research on Cancer, Lyon, France., Madia F; International Agency for Research on Cancer, Lyon, France., Schubauer-Berigan MK; International Agency for Research on Cancer, Lyon, France.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 May; Vol. 25 (5), pp. 546-548. Date of Electronic Publication: 2024 Apr 12.